155 related articles for article (PubMed ID: 11606126)
1. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
[TBL] [Abstract][Full Text] [Related]
2. Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin.
Martínez A; Suárez J; Shand T; Magliozzo RS; Sánchez-Delgado RA
J Inorg Biochem; 2011 Jan; 105(1):39-45. PubMed ID: 21113330
[TBL] [Abstract][Full Text] [Related]
3. Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.
Wang F; Habtemariam A; van der Geer EP; Fernández R; Melchart M; Deeth RJ; Aird R; Guichard S; Fabbiani FP; Lozano-Casal P; Oswald ID; Jodrell DI; Parsons S; Sadler PJ
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18269-74. PubMed ID: 16352726
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin.
Beckford F; Thessing J; Woods J; Didion J; Gerasimchuk N; Gonzalez-Sarrias A; Seeram NP
Metallomics; 2011 May; 3(5):491-502. PubMed ID: 21347491
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear η
Kanyora AK; Omondi RO; Ongoma P; Omolo JO; Welsh A; Prince S; Gichumbi J; Mambanda A; Smith GS
J Biol Inorg Chem; 2024 Mar; 29(2):251-264. PubMed ID: 38494554
[TBL] [Abstract][Full Text] [Related]
6. Ru(II)-Arene Complexes of Curcumin and Bisdesmethoxycurcumin Metabolites.
Pagliaricci N; Pettinari R; Marchetti F; Tombesi A; Pagliaricci S; Cuccioloni M; Galindo A; Fadaei-Tirani F; Hadiji M; Dyson PJ
Inorg Chem; 2024 Apr; 63(17):7955-7965. PubMed ID: 38634659
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.
Glans L; Ehnbom A; de Kock C; Martínez A; Estrada J; Smith PJ; Haukka M; Sánchez-Delgado RA; Nordlander E
Dalton Trans; 2012 Mar; 41(9):2764-73. PubMed ID: 22249579
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.
Stepanenko IN; Casini A; Edafe F; Novak MS; Arion VB; Dyson PJ; Jakupec MA; Keppler BK
Inorg Chem; 2011 Dec; 50(24):12669-79. PubMed ID: 22111668
[TBL] [Abstract][Full Text] [Related]
9. Organometallic
Betanzos-Lara S; Habtemariam A; Clarkson GJ; Sadler PJ
Eur J Inorg Chem; 2011 Jul; 2011(21):3257-3264. PubMed ID: 23956682
[TBL] [Abstract][Full Text] [Related]
10. Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity.
Gatti A; Habtemariam A; Romero-Canelón I; Song JI; Heer B; Clarkson GJ; Rogolino D; Sadler PJ; Carcelli M
Organometallics; 2018 Mar; 37(6):891-899. PubMed ID: 29681675
[TBL] [Abstract][Full Text] [Related]
11. Osmium-arene complexes with high potency towards Mycobacterium tuberculosis.
Coverdale JPC; Guy CS; Bridgewater HE; Needham RJ; Fullam E; Sadler PJ
Metallomics; 2021 Apr; 13(4):. PubMed ID: 33693931
[TBL] [Abstract][Full Text] [Related]
12. Osmium Arene Germyl, Stannyl, Germanate, and Stannate Complexes as Anticancer Agents.
Nabiyeva T; Roufosse B; Odachowski M; Baumgartner J; Marschner C; Verma AK; Blom B
ACS Omega; 2021 Jul; 6(29):19252-19268. PubMed ID: 34337263
[TBL] [Abstract][Full Text] [Related]
13. Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity.
Adhireksan Z; Davey GE; Campomanes P; Groessl M; Clavel CM; Yu H; Nazarov AA; Yeo CH; Ang WH; Dröge P; Rothlisberger U; Dyson PJ; Davey CA
Nat Commun; 2014 Mar; 5():3462. PubMed ID: 24637564
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium Complexes with N-Bound 2-Pyridonato Ligand as O-Donors: A New Synthetic Approach and the Effect on Reactivity.
Moždiak O; Tydlitát J; Růžičková Z; Dostál L; Jambor R
Chempluschem; 2024 Apr; 89(4):e202300525. PubMed ID: 37916533
[TBL] [Abstract][Full Text] [Related]
15. Molecular insight into the structural and functional aspects of arene Ru(II) complexes bearing bulky thiourea ligands.
Pathan J; Tripathi DK; Poluri KM; Chalana A; Adhikari S
J Inorg Biochem; 2024 May; 257():112584. PubMed ID: 38735072
[TBL] [Abstract][Full Text] [Related]
16. Altered DNA binding and amplification of human breast cancer suppressor gene BRCA1 induced by a novel antitumor compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)].
Chakree K; Ovatlarnporn C; Dyson PJ; Ratanaphan A
Int J Mol Sci; 2012 Oct; 13(10):13183-202. PubMed ID: 23202946
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide Ligand.
Mishra A; Jung H; Park JW; Kim HK; Kim H; Stang PJ; Chi KW
Organometallics; 2012 May; 31(9):3519-3526. PubMed ID: 22639481
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium/η
Chen K; Ma Y; Lin Y; Li JY; Shi H
J Am Chem Soc; 2024 May; ():. PubMed ID: 38819396
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic Study of the Interactions of Ruthenium-Ketoconazole Complexes of Known Antiparasitic Activity with Human Serum Albumin and Apotransferrin.
Estrada JG; Sánchez-Delgado RA
J Mex Chem Soc; 2013; 57(3):169-174. PubMed ID: 24391686
[TBL] [Abstract][Full Text] [Related]
20. Organometallic Chirality Sensing via "Click"-Like η
Nelson E; Bertke JA; Thanzeel FY; Wolf C
Angew Chem Int Ed Engl; 2024 Apr; ():e202404594. PubMed ID: 38634562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
